NEW YORK (GenomeWeb News) – Next-generation sequencing-based cancer testing firm OncoDNA has been chosen by the National Blood and Cancer Center in Saudi Arabia as a preferred supplier of molecular diagnostic tests to parts of the Middle East.

Under the terms of the agreement, OncoDNA will make available its OncoDEEP DX and OncoDEEP Clinical cancer panels to Gulf Cooperation Council countries, comprising Saudi Arabia, Bahrain, Kuwait, Oman, Qatar, and the United Arab Emirates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.